These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24574667)

  • 1. Oral lesions associated with Nevirapine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A report of 10 cases.
    Reddy RB; Shekar PC; Chandra KL; Aravind R
    J Oral Maxillofac Pathol; 2013 Sep; 17(3):431-5. PubMed ID: 24574667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
    Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
    Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal Nevirapine-Induced Toxic Epidermal Necrolysis in a HIV Infected Patient.
    Paik S; Sen S; Era N; Saha B; Tripathi SK
    J Clin Diagn Res; 2016 Mar; 10(3):FD03-6. PubMed ID: 27134891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
    Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
    Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Fagot JP; Mockenhaupt M; Bouwes-Bavinck JN; Naldi L; Viboud C; Roujeau JC;
    AIDS; 2001 Sep; 15(14):1843-8. PubMed ID: 11579247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility.
    Ciccacci C; Latini A; Politi C; Mancinelli S; Marazzi MC; Novelli G; Palombi L; Borgiani P
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1253-1259. PubMed ID: 28689274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yan Q; Liu X; Lei H; Liu R; Hu Y
    Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.
    Oshikoya KA; Ogunyinka IA; Ogar CK; Abiola A; Ibrahim A; Oreagba IA
    Ther Adv Drug Saf; 2020; 11():2042098620905998. PubMed ID: 32110375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine.
    Ciccacci C; Politi C; Mancinelli S; Ciccacci F; Lucaroni F; Novelli G; Marazzi MC; Palombi L; Borgiani P
    J Antimicrob Chemother; 2018 Aug; 73(8):2137-2140. PubMed ID: 29762688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women.
    Knight L; Todd G; Muloiwa R; Matjila M; Lehloenya RJ
    PLoS One; 2015; 10(8):e0135501. PubMed ID: 26267659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.
    Çekiç Ş; Canıtez Y; Sapan N
    Turk Pediatri Ars; 2016 Sep; 51(3):152-158. PubMed ID: 27738400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
    Al Rajaibi R; Al Rumhi T; Al Abri AM
    Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
    Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 17. A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility.
    Ciccacci C; Rufini S; Mancinelli S; Buonomo E; Giardina E; Scarcella P; Marazzi MC; Novelli G; Palombi L; Borgiani P
    Int J Mol Sci; 2015 Mar; 16(3):5830-8. PubMed ID: 25775161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.
    Borgiani P; Di Fusco D; Erba F; Marazzi MC; Mancinelli S; Novelli G; Palombi L; Ciccacci C
    Eur J Clin Pharmacol; 2014 Mar; 70(3):275-8. PubMed ID: 24322967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.
    Arora R; Pande RK; Panwar S; Gupta V
    Indian J Crit Care Med; 2021 May; 25(5):575-579. PubMed ID: 34177178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.